MPG.eBooks - Description: Drugs for chronic hepatitis C infection

Cover Image

Read Now

Drugs for chronic hepatitis C infection cost-effectiveness analysis

The objective of this study was to assess the comparative cost effectiveness of regimens for the treatment of chronic hepatitis C (CHC) infection (genotypes 1 to 4)

Bibliographic Details
Main Authors:	Wong, William, Krahn, Murray (Author), Lee, Karen M. (Author), Singh, Sumeet (Author)
Corporate Author:	Canadian Agency for Drugs and Technologies in Health
Format:	eBook
Language:	English
Published:	Ottawa (ON) Canadian Agency for Drugs and Technologies in Health 2016, January 2016
Series:	CADTH therapeutic review
Subjects:	Canada Antiviral Agents / Economics Cost-benefit Analysis Antiviral Agents / Therapeutic Use Hepatitis C, Chronic / Drug Therapy
Online Access:	https://www.ncbi.nlm.nih.gov/books/NBK355799
Collection:	National Center for Biotechnology Information - Collection details see MPG.ReNa

Description
Summary:	The objective of this study was to assess the comparative cost effectiveness of regimens for the treatment of chronic hepatitis C (CHC) infection (genotypes 1 to 4)
Physical Description:	1 PDF file (x, 123 pages) illustrations (some color)